140 related articles for article (PubMed ID: 22575418)
41. Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin.
Undas A; Placzkiewicz-Jankowska E; Zieliński L; Tracz W
Thromb Haemost; 2007 Jun; 97(6):1056-8. PubMed ID: 17549314
[No Abstract] [Full Text] [Related]
42. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D
Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
[TBL] [Abstract][Full Text] [Related]
43. Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Platelets; 2011; 22(3):188-95. PubMed ID: 21231857
[TBL] [Abstract][Full Text] [Related]
44. Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin.
Lordkipanidzé M; Diodati JG; Turgeon J; Schampaert E; Palisaitis DA; Pharand C
Int J Cardiol; 2010 Aug; 143(1):43-50. PubMed ID: 19215991
[TBL] [Abstract][Full Text] [Related]
45. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
[TBL] [Abstract][Full Text] [Related]
46. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation.
Tantry US; Bliden KP; Gurbel PA
J Am Coll Cardiol; 2005 Nov; 46(9):1705-9. PubMed ID: 16256872
[TBL] [Abstract][Full Text] [Related]
47. Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery.
Brambilla M; Parolari A; Camera M; Colli S; Eligini S; Centenaro C; Anselmo A; Alamanni F; Tremoli E
Thromb Haemost; 2010 Mar; 103(3):516-24. PubMed ID: 20076848
[TBL] [Abstract][Full Text] [Related]
48. Genetic determinants of response to aspirin: appraisal of 4 candidate genes.
Lordkipanidzé M; Diodati JG; Palisaitis DA; Schampaert E; Turgeon J; Pharand C
Thromb Res; 2011 Jul; 128(1):47-53. PubMed ID: 21429568
[TBL] [Abstract][Full Text] [Related]
49. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
Kobzar G; Mardla V; Samel N
Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
[TBL] [Abstract][Full Text] [Related]
50. Reduced aspirin responsiveness as assessed by impedance aggregometry is not associated with adverse outcome after cardiac surgery in a small low-risk cohort.
Bolliger D; Filipovic M; Matt P; Tanaka KA; Gregor M; Zenklusen U; Seeberger MD; Lurati Buse G
Platelets; 2016; 27(3):254-61. PubMed ID: 26367099
[TBL] [Abstract][Full Text] [Related]
51. Platelet function assessed by whole-blood aggregometry in patients undergoing non-cardiac surgery.
Oscarsson A; Öster S; Fredrikson M; Lindahl TL; Eintrei C
Eur J Anaesthesiol; 2011 May; 28(5):363-9. PubMed ID: 21499200
[TBL] [Abstract][Full Text] [Related]
52. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
[TBL] [Abstract][Full Text] [Related]
53. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
[TBL] [Abstract][Full Text] [Related]
54. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin.
Pettinella C; Romano M; Stuppia L; Santilli F; Liani R; Davì G
Thromb Haemost; 2009 Apr; 101(4):687-90. PubMed ID: 19350112
[TBL] [Abstract][Full Text] [Related]
55. Serum thromboxane B2 compared to five other platelet function tests for the evaluation of aspirin effect in stable cardiovascular disease.
Kidson-Gerber G; Weaver J; Gemmell R; Prasan AM; Chong BH
Heart Lung Circ; 2010 Apr; 19(4):234-42. PubMed ID: 20144559
[TBL] [Abstract][Full Text] [Related]
56. Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease.
Lordkipanidzé M; Pharand C; Schampaert E; Palisaitis DA; Diodati JG
Int J Cardiol; 2011 Jul; 150(1):39-44. PubMed ID: 20207433
[TBL] [Abstract][Full Text] [Related]
57. Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness.
Armstrong PC; Dhanji AR; Truss NJ; Zain ZN; Tucker AT; Mitchell JA; Warner TD
Thromb Haemost; 2009 Oct; 102(4):772-8. PubMed ID: 19806265
[TBL] [Abstract][Full Text] [Related]
58. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
[TBL] [Abstract][Full Text] [Related]
59. Platelet hyporesponsiveness to acetylsalicylic acid can be transferred by plasma in humans.
Anger K; Kempfert J; Kostelka M; Mohr FW; Dhein S
Pharmacology; 2010; 85(4):241-7. PubMed ID: 20332671
[TBL] [Abstract][Full Text] [Related]
60. Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease.
Maree AO; Curtin RJ; Dooley M; Conroy RM; Crean P; Cox D; Fitzgerald DJ
J Am Coll Cardiol; 2005 Oct; 46(7):1258-63. PubMed ID: 16198840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
